A new study shows that lung stem cell secretions -- specifically exosomes and secretomes -- delivered via nebulizer, can help repair lung injuries due to multiple types of pulmonary fibrosis in mice and rats.
Researchers describe the benefits of in-home noninvasive ventilation therapy, which includes a type referred to as bilevel positive airway pressure, or BiPAP -- for many patients with chronic obstructive pulmonary disease (COPD). The team identified a number of benefits, including reduced mortality, fewer hospital admissions, lower risk of intubation, improved shortness of breath, and fewer emergency department visits.
Stiff collagen and stretchy elastin fibers packed together in rows allow the respiratory system to stretch and snap back into shape. Scientists previously thought these fibers govern the mechanics of the airways due to their composition. New research has instead observed that differences in the shape and form of tissue fibers influence respiratory elasticity. These findings will help scientists better understand lung diseases, from chronic diseases like COPD to the lung ailment associated with vaping.
People who carry around unhealthy amounts of weight don't just have heart disease and diabetes to worry about. Obesity is implicated in two thirds of the leading causes of death from non-communicable diseases worldwide and the risk of certain diseases differs for men and women.
A new study shows that smoking even a few cigarettes a day is harmful to lungs and that former smokers continue to lose lung function at a faster rate than never-smokers for decades after quitting.
In a proof-of-concept experiment, researchers say they have successfully used microscopic human-made particles to predict the severity of patients' chronic obstructive pulmonary disease (COPD) by measuring how quickly the particles move through mucus samples. The technique, say the researchers, could eventually help doctors deliver more effective treatments sooner.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that's often associated with a variety of health problems, including chronic muscle pain and insomnia. Psychoactive drug classes, like cannabinoids, are often prescribed to help reduce pain, promote sleep and decrease breathlessness. A study has found that older adults with COPD were twice as likely to use prescription synthetic oral cannabinoids compared to older adults without COPD, raising safety concerns.
Scientists found that the lungs of vapers -- like the lungs of smokers -- have elevated levels of protease enzymes, a condition known to cause emphysema in smokers. The researchers also found that the nicotine in vaping liquids is responsible for the increase in protease enzymes.
Scientists investigating the effect of air pollution on lung health, in an animal model, have concluded that even low levels of exposure can have a detrimental effect on the lungs. They say the results have implications for government agencies responsible for urban planning.
A simple finger-prick blood test could help prevent unnecessary prescribing of antibiotics for people with the lung condition chronic obstructive pulmonary disease (COPD), according to a new study.
A study of more than 300,000 people has found that exposure to outdoor air pollution is linked to decreased lung function and an increased risk of developing COPD. Lung function normally declines as we age, but the new research suggests that air pollution may contribute to the ageing process and adds to the evidence that breathing in polluted air harms the lungs.
Good heart and lung (cardiorespiratory) fitness in middle age is associated with a lower long term risk of chronic lung disease (COPD), suggests new research.
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a new statement.
A global study shows people born very preterm or with very low birthweight have a high risk of lung disease and are not reaching their full airway capacity by early adulthood.
New research shows that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe exacerbations, and eosinophilic inflammation.